Blood pressure medication shortages are a growing concern as the supply chain faces potential collapse. An expert has highlighted that the pricing of certain medications is driving pharmaceutical companies away from the British market. This has led to supply issues for various blood pressure treatments, with local pharmacists reporting difficulties in maintaining stocks of routine medicines such as propranolol and ramipril. The core issue is the low prices set for high-volume generic drugs in the UK, making it unattractive for manufacturers to distribute their medicines here. During periods of limited stock, the wholesale price of these items can rise significantly, causing sudden price hikes of up to 500%. The Department of Health and Social Care (DHSC) has reported that the 'vast majority' of licensed medicines in the UK remain in good supply, but ministers have recently added common medications like aspirin to a restricted export list to protect domestic stocks. Healthcare professionals are working to find suitable alternatives to ensure patient safety, and the sector is calling for a fundamental review of how the NHS pays for medications to ensure long-term stability. Patients can support their local pharmacies by writing to their local MP and raising concerns about adequate remuneration.
